|
03.07.2026 10:02:11
|
Celltrion Q2 Operating Income Jumps
(RTTNews) - Celltrion, Inc. (068270.KS), a biopharmaceutical company, on Friday reported higher operating income and sales in the second quarter of 2026 compared with the same period last year.
For the second quarter, operating income also jumped to KRW 751.9 billion from KRW 391.9 billion
Sales for the period increased to KRW 2.45 trillion from KRW 1.80 trillion in the previous year.
Celltrion closed trading 3.96% higher at KRW 183,600 on the Korean Stock Exchange.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!